CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
93.40
-2.50 (-2.61%)
Apr 29, 2026, 1:30 PM CST

CH Biotech R&D Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
394.13478.86939.93530.02321.01
Upgrade
Short-Term Investments
3.143.283.073.075.78
Upgrade
Cash & Short-Term Investments
397.27482.13943533.1326.79
Upgrade
Cash Growth
-17.60%-48.87%76.89%63.13%-0.93%
Upgrade
Accounts Receivable
246.02162.83106.0733.3161.14
Upgrade
Other Receivables
53.5956.6244.842.9729.13
Upgrade
Receivables
299.61219.45150.8776.27190.27
Upgrade
Inventory
153.48122.1119.21177.26125.01
Upgrade
Prepaid Expenses
18.9326.518.5912.9910.74
Upgrade
Other Current Assets
2.312.43.764.071.71
Upgrade
Total Current Assets
871.59852.591,235803.69654.53
Upgrade
Property, Plant & Equipment
2,6312,7182,3612,3652,349
Upgrade
Long-Term Investments
2629.129.36--
Upgrade
Goodwill
2.452.452.452.452.45
Upgrade
Other Intangible Assets
8.753.433.715.825.39
Upgrade
Long-Term Deferred Tax Assets
6.792.843.2122.23
Upgrade
Other Long-Term Assets
27.5920.714.3716.0815.24
Upgrade
Total Assets
3,5743,6293,6493,1953,029
Upgrade
Accounts Payable
9.048.849.269.6220.71
Upgrade
Accrued Expenses
0.190.230.350.410.19
Upgrade
Short-Term Debt
365290190120188
Upgrade
Current Portion of Long-Term Debt
107.28107.28385.6120140.76
Upgrade
Current Portion of Leases
25.5624.3328.1821.6216.83
Upgrade
Current Income Taxes Payable
66.854.11119.2876.0268.35
Upgrade
Current Unearned Revenue
0.170.320.470.30.35
Upgrade
Other Current Liabilities
147.47161.82149.19119.5693.66
Upgrade
Total Current Liabilities
721.51646.93882.32467.52528.84
Upgrade
Long-Term Debt
31.98189.26-385.6523.18
Upgrade
Long-Term Leases
134.5136.46241.38247.66253.51
Upgrade
Pension & Post-Retirement Benefits
-7.25.364.26-
Upgrade
Long-Term Deferred Tax Liabilities
-2.38-2.56-
Upgrade
Other Long-Term Liabilities
0.480.21---
Upgrade
Total Liabilities
888.48982.441,1291,1081,306
Upgrade
Common Stock
1,0281,0281,028970.83844.2
Upgrade
Additional Paid-In Capital
718.53718.26717.64331.32331.32
Upgrade
Retained Earnings
930.12877.19771.2782.37570.21
Upgrade
Comprehensive Income & Other
9.3522.423.33.16-22.52
Upgrade
Total Common Equity
2,6862,6462,5202,0881,723
Upgrade
Minority Interest
-0.87---
Upgrade
Shareholders' Equity
2,6862,6472,5202,0881,723
Upgrade
Total Liabilities & Equity
3,5743,6293,6493,1953,029
Upgrade
Total Debt
664.33747.33845.16894.891,122
Upgrade
Net Cash (Debt)
-267.05-265.1997.84-361.79-795.48
Upgrade
Net Cash Per Share
-2.59-2.571.00-3.67-8.11
Upgrade
Filing Date Shares Outstanding
102.8102.8102.897.0897.08
Upgrade
Total Common Shares Outstanding
102.8102.8102.897.0897.08
Upgrade
Working Capital
150.08205.66353.1336.16125.69
Upgrade
Book Value Per Share
26.1325.7424.5221.5017.75
Upgrade
Tangible Book Value
2,6752,6402,5142,0791,715
Upgrade
Tangible Book Value Per Share
26.0225.6824.4621.4217.67
Upgrade
Land
502.39546.51143.24143.26109.81
Upgrade
Buildings
2,0181,9491,9051,8641,448
Upgrade
Machinery
892.56823.54576.15476.33358.65
Upgrade
Construction In Progress
35.6840.1260.573.28508.86
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.